Snap Plans New Spectacles, Weinstein Co. Strikes Last Minute Deal for Sale
Snap is planning to release new versions of its hugely unpopular Spectacles. Cheddar senior reporter Alex Heath joins us to share the details on the company's plan for the new smart glasses. Snap will release a second version of its Spectacles this fall and is aiming to release a third version sometime thereafter. The second version will include performance improvements and the third will have increased camera technology. Snap had to take a $40 million loss on its first version of Spectacles due to lack of interest.
The Weinstein Co. lives to fight another day after a last-minute deal emerged Thursday night. An investor group will buy the Weinstein Co. in a deal worth $50 million. Maria Contreras-Sweet, President Obama's former Small Business Administration head, is leading the negotiations. In a statement, she said she looks forward to launching a "new company, with a new board and a new vision." This comes days after the Weinstein Co. filed for bankruptcy.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
